New Analyst Forecast: $KPTI Given $27.0 Price Target - Nasdaq
4 days ago • Google News
Karyopharm Therapeutics Inc (KPTI)
US$ 6.14-9.04%
Price Chart
Key Statistics
Market Cap
$ 36.63M
P/E Ratio
0.00
Revenue (TTM)
$ 142.13M
Volume
99.4K
52W High
$ 16.95
52W Low
$ 3.51
Dividend Yield
0.00%
Beta
0.23
Technicals
50-Day MA
4.8679
200-Day MA
8.4322
52 Week High
16.95
52 Week Low
3.51
About KPTI
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases in.
Employees
279
Headquarters
Newton, MA
CEO
Mr. Richard A. Paulson M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg